Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations.
Meyer A, Guffroy A, Blaison G, Dieudonne Y, Amoura Z, Bonnotte B, Fiehn C, Kieffer P, Lorenz HM, Magy-Bertrand N, Maurier F, Pennaforte JL, Peter HH, Schwarting A, Sibilia J, Arnaud L, Martin T, Voll RE, Korganow AS; LBBR/Rarenet group. Meyer A, et al. Among authors: lorenz hm. Lupus Sci Med. 2020 Jul;7(1):e000399. doi: 10.1136/lupus-2020-000399. Lupus Sci Med. 2020. PMID: 32616563 Free PMC article.
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE. Alexander T, et al. Among authors: lorenz hm. Ann Rheum Dis. 2015 Jul;74(7):1474-8. doi: 10.1136/annrheumdis-2014-206016. Epub 2015 Feb 20. Ann Rheum Dis. 2015. PMID: 25710470 Free PMC article. Clinical Trial.
Etiopathogenesis of systemic lupus erythematosus.
Herrmann M, Winkler T, Gaipl U, Lorenz H, Geiler T, Kalden JR. Herrmann M, et al. Int Arch Allergy Immunol. 2000 Sep;123(1):28-35. doi: 10.1159/000024421. Int Arch Allergy Immunol. 2000. PMID: 11014969 Review.
Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial.
Stephan M, Tascilar K, Yalcin-Mutlu M, Hagen M, Haschka J, Reiser M, Hartmann F, Kleyer A, Hueber AJ, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J. Stephan M, et al. Among authors: lorenz hm. J Clin Med. 2023 May 28;12(11):3723. doi: 10.3390/jcm12113723. J Clin Med. 2023. PMID: 37297917 Free PMC article.
Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairments.
Maurus J, Terzer T, Benner A, Goisser S, Eidam A, Roth A, Janssen M, Jaramillo S, Lorenz HM, Micol W, Hauer K, Müller-Tidow C, Bauer JM, Jordan K, Neuendorff NR. Maurus J, et al. Among authors: lorenz hm. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):264-275. doi: 10.1002/jcsm.12871. Epub 2021 Dec 12. J Cachexia Sarcopenia Muscle. 2022. PMID: 34898035 Free PMC article.
CAR T-Cell Therapy in Autoimmune Disease.
Merkt W, Lorenz HM, Schmitt M. Merkt W, et al. Among authors: lorenz hm. N Engl J Med. 2024 May 2;390(17):1628-1629. doi: 10.1056/NEJMc2403705. N Engl J Med. 2024. PMID: 38692297 No abstract available.
Fibroblast Activation Protein Inhibitor-Positron Emission Tomography in Aortitis: Fibroblast pathology in active inflammation and remission.
Röhrich M, Rosales JJ, Hoppner J, Kvacskay P, Blank N, Loi L, Paech D, Schreckenberger M, Giesel F, Kauczor HU, Lorenz HM, Haberkorn U, Merkt W. Röhrich M, et al. Among authors: lorenz hm. Rheumatology (Oxford). 2024 Apr 22:keae225. doi: 10.1093/rheumatology/keae225. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38648749
340 results